Most patients say they underestimated the side effects during titration, particularly nausea, reduced appetite, and fatigue in the first few weeks
Same considerations as BPC-157 apply
therefore, we used VDAC2 staining as a second marker of mitochondrial abundance, and quantified staining in tumour or stromal compartments using QuPath software 27 (Extended Data Fig
Braverman KD, Pearce EN
How Fast Will I Lose Weight
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
